BioPorto recalls ProNephro AKI reagent kits after non-validated reagent rework
This recall connects a manufacturing-process deviation directly to the reliability of a diagnostic result used in acute kidney injury assessment. It is relevant to IVD quality teams because the FDA record links the non-validated rework to potential downstream diagnostic, treatment, and monitoring consequences rather than a purely administrative nonconformity.